T1	Concept 17 27	SARS-CoV-2
T2	Concept 63 83	Bat-SARSr-CoV RaTG13
R1	causes Arg1:T2 Arg2:T1	
T3	Concept 110 122	substitution
A1	Emphasized T3
T4	Concept 99 109	synonymous
R2	has-property Arg1:T3 Arg2:T4	
T5	Concept 131 141	SARS-CoV-2
R3	has-part Arg1:T3 Arg2:T5	
T6	Concept 146 159	RaTG13 strain
R4	has-part Arg1:T3 Arg2:T6	
T7	Concept 185 191	genome
T8	Concept 174 184	SARS-CoV-2
R5	has-property Arg1:T7 Arg2:T8	
T9	Action 160 169	suggested
T10	Action 232 241	selection
T12	Concept 211 219	negative
T13	Concept 220 230	(purifying
R6	is-a Arg1:T13 Arg2:T10	
A2	Emphasized T10
R7	is-a Arg1:T12 Arg2:T10	
R8	target Arg1:T10 Arg2:T7	
R9	target Arg1:T9 Arg2:T10	
T11	Concept 353 362	mutations
T14	Concept 342 352	synonymous
R10	has-property Arg1:T11 Arg2:T14	
T17	Concept 431 456	other coronavirus strains
T16	Concept 396 406	SARS-CoV-2
T18	Concept 411 417	RaTG13
R12	in-context Arg1:T11 Arg2:T16	
R13	in-context Arg1:T11 Arg2:T18	
R14	in-context Arg1:T17 Arg2:T11	
A4	Diminished T17
A3	Emphasized T16
A5	Emphasized T18
T15	Concept 477 486	mutations
T19	Concept 466 476	nucleotide
R11	has-property Arg1:T15 Arg2:T19	
T20	Action 492 500	enriched
T21	Concept 504 518	T:C transition
R15	in-context Arg1:T20 Arg2:T21	
R16	target Arg1:T20 Arg2:T15	
T22	Concept 519 524	CD147
T23	Concept 536 546	associated
A6	Emphasized T23
R17	has-property Arg1:T22 Arg2:T23	
T24	Concept 563 571	invasion
R18	target Arg1:T23 Arg2:T24	
T25	Concept 552 562	SARS-CoV-2
R19	has-property Arg1:T24 Arg2:T25	
T26	Concept 576 586	host cells
R20	target Arg1:T24 Arg2:T26	
T27	Concept 592 594	SP
T28	Action 595 600	binds
R21	subject Arg1:T28 Arg2:T27	
T29	Concept 604 622	cellular receptors
R22	target Arg1:T28 Arg2:T29	
T30	Action 626 633	mediate
R23	causes Arg1:T28 Arg2:T30	
T31	Concept 634 643	infection
R24	target Arg1:T30 Arg2:T31	
T32	Concept 647 657	host cells
R25	target Arg1:T31 Arg2:T32	
T33	Concept 756 767	interaction
T34	Concept 773 785	pig 146 ACE2
R26	in-context Arg1:T33 Arg2:T34	
T35	Concept 794 803	favorable
R27	has-property Arg1:T33 Arg2:T35	
A7	Emphasized T35
T36	Action 819 826	isolate
R28	causes Arg1:T35 Arg2:T36	
T37	Concept 808 818	SARS-CoV-2
R29	subject Arg1:T37 Arg2:T36	
T38	Concept 847 849	Kd
T40	Concept 865 871	lesser
R30	is-a Arg1:T38 Arg2:T40	
T39	Concept 859 864	folds
R31	has-part Arg1:T38 Arg2:T39	
T41	Concept 853 858	147 3
R32	has-property Arg1:T39 Arg2:T41	
T42	Concept 884 894	SARS-CoV-2
T43	Action 872 880	compared
R33	in-context Arg1:T40 Arg2:T43	
R34	target Arg1:T43 Arg2:T42	
T44	Concept 900 915	binding surface
T45	Concept 919 927	olaparib
T46	Concept 931 947	SARS-CoV-2-N-NTD
T47	Concept 995 1001	CVL218
R35	has-part Arg1:T44 Arg2:T45	
R36	in-context Arg1:T44 Arg2:T46	
T48	Reference 987 991	that
R37	has-part Arg1:T48 Arg2:T47	
T49	Concept 951 958	similar
R38	has-property Arg1:T44 Arg2:T49	
A8	Diminished T49
R39	target Arg1:T49 Arg2:T48	
